Dr. Lance Augustin

Project Title: 
Bacterially Delivered Tumor-Targeted Anticancer Immunotherapy

These researchers engineer virulence-attenuated bacteria to secrete immunomodulatory molecules in tumors. The bacterial strains are tested for efficacy and mechanism in mouse models of cancer. When a sufficiently efficacious anticancer therapy is demonstrated in mouse models it will be translated to human clinical trials.

Project Investigators

Dr. Lance Augustin
Liming Milbauer PhD
Associate Professor Daniel Saltzman
Professor Janet Schottel
Are you a member of this group? Log in to see more information.